Clinical Performance Study of Safety Test ABO Device
ConditionTransfusion Reaction
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorDiagast
About this trial
The study aims to confirm the performance equivalence of the in vitro diagnostic device Safety Test ABO with the ABTest Card device.
Eligibility criteria
Qualifiers
Age ≥ 18 years old for the category marked with *.
Undergo capillary blood sampling;
Patient in need of blood transfusion without any pathology known to have an impact on transfusion act*;
Patient in need of blood transfusion suffering from congenital erythrocyte pathology (sickle cell anaemia, beta thalassemia)*
Disqualifiers
Pregnant woman;
Person deprived of liberty;
Unconscious person;
Person under guardianship or trusteeship;
Trial design
Treatments tested in this trial
- Safety Test ABO and ABTest Card®
Treatment groups
No treatment groups listed
Sponsors and collaborators
Diagast
Lead sponsor
Soladis
Collaborator
Source ClinicalTrials.gov